164 related articles for article (PubMed ID: 22169281)
21. Clinical significance of P-glycoprotein expression and function for response to induction chemotherapy, relapse rate and overall survival in acute leukemia.
Wuchter C; Leonid K; Ruppert V; Schrappe M; Büchner T; Schoch C; Haferlach T; Harbott J; Ratei R; Dörken B; Ludwig WD
Haematologica; 2000 Jul; 85(7):711-21. PubMed ID: 10897123
[TBL] [Abstract][Full Text] [Related]
22. [The relationship between expression of the vascular endothelial growth factor and acute leukemia subtype].
Ye XJ; Lin MF
Zhonghua Xue Ye Xue Za Zhi; 2005 Jun; 26(6):363-6. PubMed ID: 16185486
[TBL] [Abstract][Full Text] [Related]
23. A Novel LSD1 Inhibitor T-3775440 Disrupts GFI1B-Containing Complex Leading to Transdifferentiation and Impaired Growth of AML Cells.
Ishikawa Y; Gamo K; Yabuki M; Takagi S; Toyoshima K; Nakayama K; Nakayama A; Morimoto M; Miyashita H; Dairiki R; Hikichi Y; Tomita N; Tomita D; Imamura S; Iwatani M; Kamada Y; Matsumoto S; Hara R; Nomura T; Tsuchida K; Nakamura K
Mol Cancer Ther; 2017 Feb; 16(2):273-284. PubMed ID: 27903753
[TBL] [Abstract][Full Text] [Related]
24. Enhancer Activation by Pharmacologic Displacement of LSD1 from GFI1 Induces Differentiation in Acute Myeloid Leukemia.
Maiques-Diaz A; Spencer GJ; Lynch JT; Ciceri F; Williams EL; Amaral FMR; Wiseman DH; Harris WJ; Li Y; Sahoo S; Hitchin JR; Mould DP; Fairweather EE; Waszkowycz B; Jordan AM; Smith DL; Somervaille TCP
Cell Rep; 2018 Mar; 22(13):3641-3659. PubMed ID: 29590629
[TBL] [Abstract][Full Text] [Related]
25. Analysis of drug resistance-associated proteins expressions of patients with the recurrent of acute leukemia via protein microarray technology.
Zeng DF; Zhang J; Zhu LD; Kong PY; Li JP; Zhang X; Xu W; Wang JL; Pen XG; Wang P; Liu SH
Eur Rev Med Pharmacol Sci; 2014; 18(4):537-43. PubMed ID: 24615181
[TBL] [Abstract][Full Text] [Related]
26. High expression of the histone demethylase LSD1 associates with cancer cell proliferation and unfavorable prognosis in tongue cancer.
Yuan C; Li Z; Qi B; Zhang W; Cheng J; Wang Y
J Oral Pathol Med; 2015 Feb; 44(2):159-65. PubMed ID: 25040359
[TBL] [Abstract][Full Text] [Related]
27. Androgen receptor coactivators lysine-specific histone demethylase 1 and four and a half LIM domain protein 2 predict risk of prostate cancer recurrence.
Kahl P; Gullotti L; Heukamp LC; Wolf S; Friedrichs N; Vorreuther R; Solleder G; Bastian PJ; Ellinger J; Metzger E; Schüle R; Buettner R
Cancer Res; 2006 Dec; 66(23):11341-7. PubMed ID: 17145880
[TBL] [Abstract][Full Text] [Related]
28. Natural protoberberine alkaloids, identified as potent selective LSD1 inhibitors, induce AML cell differentiation.
Li ZR; Suo FZ; Guo YJ; Cheng HF; Niu SH; Shen DD; Zhao LJ; Liu ZZ; Maa M; Yu B; Zheng YC; Liu HM
Bioorg Chem; 2020 Apr; 97():103648. PubMed ID: 32065882
[TBL] [Abstract][Full Text] [Related]
29. [Determination of leukemia stem cells in childhood acute myeloid leukemia and its clinical significance].
Wang D; Tang YM; Xu XJ; Shen HQ; Qian BQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Aug; 18(4):952-8. PubMed ID: 20723307
[TBL] [Abstract][Full Text] [Related]
30. Expressions of cyclin B1 and p21cipl in adult acute leukemia and their correlation.
Ma WD; Xu SR; Yan YL; Guo XN; Qiao SK; Xue F; Gao XL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Oct; 13(5):751-8. PubMed ID: 16277836
[TBL] [Abstract][Full Text] [Related]
31. Lysine-Specific Demethylase 1A as a Promising Target in Acute Myeloid Leukemia.
Magliulo D; Bernardi R; Messina S
Front Oncol; 2018; 8():255. PubMed ID: 30073149
[TBL] [Abstract][Full Text] [Related]
32. [Expression of pig7 in acute leukemia and its clinical significance].
Wang DH; Wang Y; Wang M; Liu H; Xu ZF; Rao Q; Meng JH; Wang JX
Zhonghua Xue Ye Xue Za Zhi; 2007 Aug; 28(8):532-6. PubMed ID: 18078129
[TBL] [Abstract][Full Text] [Related]
33. [Expression of HOXB4, PRDM16 and HOXA9 in Patients with Acute Myeloid Leukemia and Its Clinical Significance].
Li L; Zhao CT; Cui BL; Wu SL; Liu XD; Su Z; Yang J; Wang W; Cui ZG; Zhao HG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Apr; 24(2):326-31. PubMed ID: 27150986
[TBL] [Abstract][Full Text] [Related]
34. [Impact of disease status on outcomes of allogeneic hematopoietic stem cell transplantation in patients with refractory and relapsed acute myeloid leukemia].
Zhou QL; Tang XW; Sun AN; Qiu HY; Jin ZM; Miao M; Fu ZZ; Zhao BR; Shi XL; Chen GH; Wu DP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Aug; 20(4):954-8. PubMed ID: 22931663
[TBL] [Abstract][Full Text] [Related]
35. [Expression of Hippo signaling pathway core element MST1 in acute leukemia patients and its significance].
Xie SL; Shen JZ; Fu HY; Wu DS; Wang XT; Cao DM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Jun; 20(3):527-30. PubMed ID: 22739148
[TBL] [Abstract][Full Text] [Related]
36. [Expression and Significance of PD-L1, HSP90 and HSP90α in Serum of Patients with Acute Leukemia].
Ma XJ; Zhang FH; Sun L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Oct; 25(5):1384-1389. PubMed ID: 29070112
[TBL] [Abstract][Full Text] [Related]
37. [Expression of antiapoptotic gene aven in de novo acute myeloid leukemia patients and its clinical significance].
Geng SX; DU X; Weng JY; Zhong LY; Guo R; Lu ZS; Chen ZH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Dec; 17(6):1424-8. PubMed ID: 20030919
[TBL] [Abstract][Full Text] [Related]
38. Caloric restriction leads to druggable LSD1-dependent cancer stem cells expansion.
Pallavi R; Gatti E; Durfort T; Stendardo M; Ravasio R; Leonardi T; Falvo P; Duso BA; Punzi S; Xieraili A; Polazzi A; Verrelli D; Trastulli D; Ronzoni S; Frascolla S; Perticari G; Elgendy M; Varasi M; Colombo E; Giorgio M; Lanfrancone L; Minucci S; Mazzarella L; Pelicci PG
Nat Commun; 2024 Jan; 15(1):828. PubMed ID: 38280853
[TBL] [Abstract][Full Text] [Related]
39. [PRAME mRNA expression in newly diagnosed acute myeloid leukemia patients and its application to monitoring minimal residual disease].
Qin YZ; Li JL; Zhu HH; Li LD; Chang Y; Hao L; Wang YZ; Jiang B; Lu XJ; Liu YR; Huang XJ; Chen SS
Zhonghua Xue Ye Xue Za Zhi; 2008 Jul; 29(7):441-5. PubMed ID: 19035174
[TBL] [Abstract][Full Text] [Related]
40. Abnormal cytogenetics at date of morphologic complete remission predicts short overall and disease-free survival, and higher relapse rate in adult acute myeloid leukemia: results from cancer and leukemia group B study 8461.
Marcucci G; Mrózek K; Ruppert AS; Archer KJ; Pettenati MJ; Heerema NA; Carroll AJ; Koduru PR; Kolitz JE; Sterling LJ; Edwards CG; Anastasi J; Larson RA; Bloomfield CD
J Clin Oncol; 2004 Jun; 22(12):2410-8. PubMed ID: 15197203
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]